19 May 2013
Keywords: altea, completes, ph, ii, trials, pain, management
Article | 12 September 2005
USA-based drugmaker Altea Therapeutics has announced the completion of a Phase II clinical trial of its hydromorphone transdermal patch, used ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.